Volume 65, Issue 6 pp. 858-863
Experimental Cancer

Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines

Bruce Anthony

Bruce Anthony

Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport, LA, USA

Search for more papers by this author
Peggy Carter

Peggy Carter

Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport, LA, USA

Search for more papers by this author
Arrigo De Benedetti

Corresponding Author

Arrigo De Benedetti

Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport, LA, USA

Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA. Fax: (318)675-5180Search for more papers by this author

Abstract

The expression of the proto-oncogene, translation factor elF-4E, was examined in breast-cell lines: 5 carcinomas and 2 normal. At the protein level, elF-4E was 10 times higher in the carcinoma lines than in normal cells, which is comparable to the level found in breast-cancer biopsies. The elevation appears to be due to increased transcription, since the elF-4E mRNA was correspondingly increased. These results demonstrate that cells isolated from naturally occurring breast carcinomas maintain an elevated expression of the factor. Turnover rates for elF-4E (mRNA and protein) were determined for normal and cancer cells. We found that elF-4E mRNA is relatively stable during an 8-hr incubation with Actinomycin D, but the half-life of the protein is fairly short (≈4.5 hr). This suggests that, in proliferating cells, elF-4E may be turning over rapidly, possibly to fine-tune the changes in translation rates which occur during the cell cycle. © 1996 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.